In the afternoon of May 13, Liang Jianfen, the deputy mayor of Kaiping, led a team to visit our company to carry out research on the biomedical industry chain, accompanied by Yu Xiangyang, the deputy secretary of the Party Committee and mayor of Yueshan Town. The research symposium was held in the company's conference room 3. Yin Jinxi, the company's executive deputy general manager, Luo Yongchi, the deputy general manager, and the person in charge of Guangdong Rixing Pharmaceutical Co., Ltd. attended the symposium. At the meeting, the parties had in-depth exchanges on finding the development direction of the biomedical industry and promoting win-win cooperation between the upstream and downstream of the pharmaceutical industry chain. Through this multi-party exchange, our company is full of expectations for the future of the bio-pharmaceutical industry chain in our city. In the future development, we are confident to continuously improve the independent innovation ability and market competitiveness of enterprises,

With the continuous development of the pharmaceutical industry and the vigorous promotion of the drug consistency evaluation policy, as well as the recent frequent shortage or monopoly of raw materials, a new round of competition has emerged in the pharmaceutical industry. In order to remain invincible in the fierce competition, enterprises must focus on the development trend of the industry, comprehensively and reasonably layout their product lines, and seize the opportunity to continuously improve their own strength. The company has a comprehensive view of the industry development prospects, combined with the advantages that our drug R&D system is constantly improving and maturing, while actively carrying out the drug consistency evaluation project and the generic drug R&D pipeline, and after multiple studies and judgments, the company has focused its development on the layout of the API production base. The importance and necessity of the pharmaceutical industry supply chain is self-evident. After clarifying the development strategy and direction, the company actively seeks partners to jointly build the API production platform. Hunan Warner Pharmaceutical Co., Ltd. (hereinafter referred to as "Warner Pharmaceutical") has cooperated with our company in the supply of raw materials for decades. The two sides have established a good cooperative relationship and have a high degree of agreement in the planning and concept of self-built API base. From August 4 to 5, 2022, Huang Bendong, Chairman of Warner Pharmaceutical Co., Ltd., Xu Yan, Vice Chairman of Warner Pharmaceutical Co., Ltd. and a delegation of 8 people came to our company to discuss the cooperation of API base. Warner Pharmaceutical is an innovation-driven drug manufacturing and listing enterprise with multiple R&D centers, which can connect with global innovation resources and cover the industrial chain of traditional Chinese medicine, chemical medicine and biological macromolecular drugs. This time, the two sides discussed cooperation and seek common development, which is of great significance to the company's strategic planning.

In order to deeply connect with local parks and enterprises, support and serve the technological innovation and development of the industry, on the morning of September 27, Lin Zhanjiang, president of Jiangmen Industrial Technology Research Institute, Guangdong Academy of Sciences, and Li Jinxiang, Cuishan Lake Economic Promotion Bureau, and a delegation of four people visited our company for research and exchange. The research meeting was held in the company's conference room 3. Luo Yongchi, the company's deputy general manager, and Situ Weitong, the deputy general manager, attended the meeting. At the meeting, President Luo introduced the company's business situation, product structure, research and development status, and exchanged views with President Lin on the fierce competition and national policies in the pharmaceutical industry such as the national economic policy of the pharmaceutical industry, the industrial chain of raw materials, the evaluation of drug consistency, and the development characteristics of the generic pharmaceutical industry. After the meeting, President Lin and his delegation also visited the company's drug research institute and pilot plant, and gave a pertinent evaluation. The company has always attached great importance to scientific research and innovation. Through this research and exchange, it has deepened the communication between the enterprise and Jiangmen Institute of Industry and Research, and hopes that there will be further opportunities for industry-university-research cooperation in the future.

On the morning of October 9, Xu Qian, the general manager of Nanjing Zhongda Pharmaceutical Co., Ltd., and a party of three came to our company for business negotiation. The company's executive deputy general manager Yin Jinxi, deputy general manager Luo Yongchi, deputy general manager Liu Xiaolan, deputy general manager Hu Guobin and other leaders attended the meeting.

In order to further strengthen the fire safety education, improve the fire safety awareness of employees, and enhance the fire prevention and self-rescue ability. On the morning of October 20, 2022, our company, together with the fire brigade of Yueshan Town, Kaiping City, carried out a fire escape training drill. A total of 68 employees from all departments of the company participated in the fire drill. Before the drill, Yin Jinxi, the executive vice general manager of the company, made a mobilization speech, stressing the importance of fire safety, and hoped that employees would actively participate in the drill and seriously learn fire knowledge. This fire drill is divided into two parts. The first part is the fire emergency evacuation drill, which simulates the evacuation and emergency rescue in case of fire. The whole drill process was orderly and rapid, and the training staff initially mastered the basic methods of escape, self-rescue and mutual rescue in danger.

On the morning of November 23, Liu Jie, member of the Standing Committee of the Jiangmen Municipal Committee and Executive Vice Mayor, led a team to visit our company to carry out research work. Yu Wenfeng, member of the Standing Committee of the Kaiping Municipal Party Committee, Xie Shaomou, secretary of the Party Leadership Group of Jiangmen Municipal Market Supervision and Administration Bureau, and Yu Xiangyang, deputy secretary of the Party Committee of Yueshan Town, accompanied the survey. Luo Yongchi, deputy general manager of the company, and Situ Weitong, deputy general manager, attended the research symposium. At the meeting, Mr. Luo outlined the company's production, research and development, sales and other basic information. After carefully listening to the report, Liu got a preliminary understanding of the overall operation of the company, and proposed that relevant departments should further optimize the investment and business environment, increase government support, and encourage enterprises to become bigger and stronger.

On the morning of December 15, Liang Xilian, deputy director of Jiangmen Social Security Fund Administration, and Zhen Wenhan, director of Kaiping Social Security Fund Administration, visited our company to investigate the implementation of social security policies and publicize the spirit of the 20th CPC National Congress. The research symposium was held at the party and mass center of the company. Luo Yongchi, the vice general manager of the company, and relevant personnel of the company's social security business attended the meeting. At the meeting, Director Liang asked in detail whether the enterprise knew the policies of reducing the rate of social security and stabilizing the return of posts, and learned about the cost saved by our company's preferential policies. President Luo said that the social security preferential policy has a substantive effect on enterprises. The social security department is very timely, in place and efficient in implementing the policy and handling business, which has brought great convenience to enterprises.

On the morning of December 16, Liang Jianfen, deputy mayor of Kaiping, led a team to our company to carry out the investigation of epidemic prevention materials, accompanied by Yu Xiangyang, deputy secretary of the Party Committee and mayor of Yueshan Town. The research symposium was held in the company's conference room 3. Yin Jinxi, the company's executive deputy general manager, and Luo Yongchi, the deputy general manager, attended the symposium. At the meeting, Mr. Yin reported the production, sales and inventory of our common anti-epidemic drugs and disposable masks, such as colds, anti-bacterial and anti-viral drugs, and said that at the critical moment of the current national anti-epidemic, the company will make every effort to ensure the stability of the market supply and price stability of relevant products. In the face of the epidemic, our company took full advantage of its own advantages and went all out to strengthen measures, ensure supply and make contributions. Mayor Liang fully affirmed this and proposed that in the face of the new situation of epidemic prevention and control, we hope that enterprises will actively fulfill their social responsibilities, serve the overall situation of local epidemic prevention and control, and guide employees to establish a correct awareness of epidemic prevention. Under the premise of ensuring epidemic prevention and production safety, the company strives to improve production efficiency and ensure the production and supply of epidemic prevention drugs. We firmly believe that under the correct leadership of the superior departments, we will gather a strong joint force to fight the epidemic and contribute our own efforts to win the epidemic.

On the morning of December 23, the company donated a batch of drugs to the people's government of Yueshan Town to help the epidemic prevention and control work of the whole town. Since the emergence of the COVID-19 epidemic, the company has always shouldered social responsibility and kept an eye on the development of the epidemic. It has donated money or epidemic prevention materials to people's township government, hospitals, the Red Cross Society and other units for many times. The anti epidemic drug Binuo paracetamol pseudoephedrine tablet donated by the company to Yueshan Township is mainly used to alleviate the symptoms of fever, headache, limb pain, sneezing, runny nose, competition, sore throat, etc. caused by common cold and influenza, with a wide range of applications and definite clinical effects. Yin Jinxi, the executive vice general manager of the company, attended the donation ceremony. On behalf of Yueshan People's Government, Lu Cai'e, the chairman of Yueshan People's Congress, expressed heartfelt thanks to the company for its kindness: thank the company for its care and dedication to the people of Yueshan. This loving action has added confidence and determination to the epidemic prevention and control work in Yueshan Town. Later, Yueshan Town Government will distribute this batch of drugs to the epidemic prevention front line of the whole town in time to build a strong epidemic prevention barrier for the life and health of Yueshan people. Rooted in the people and serving the people, as a pharmaceutical enterprise growing up locally in Yueshan Town, the company has always adhered to the business philosophy of "creating a smile with heart", planted in the hot land of Red Yueshan, actively performed social responsibilities, and was enthusiastic about social welfare undertakings. In the face of the increasingly rampant COVID-19, the company will, as always, assume social responsibility, fully improve production efficiency, actively participate in public welfare undertakings, and make the greatest contribution to the healthy smile of the people!

Recently, with the adjustment of epidemic prevention and control policies and the increasing number of infected people, the risk of infection faced by employees is gradually increasing. In order to maximize the safety and health of employees, and at the same time help employees solve the problem of difficulty in purchasing drugs. After days of rush production, the company distributed a series of epidemic prevention materials to each employee at the first time, including two boxes of Pino-paracetamol pseudoephedrine tablets (I) produced by the company, 30 bags of cefaclor granules and a box of protective masks. In the face of the problem that antigens are hard to find in the market today, the company has tried every means to purchase a batch of COVID-19 antigen kits, which have been distributed to all departments and workshops, and are ready to be used by employees in need, building a defense line for employees' epidemic resistance and health. After receiving these "timely drugs", the employees of the company expressed their gratitude to the company for its care. At this tense time, the company could receive the urgently needed epidemic prevention supplies, which was a "timely help" for the company. The employees also said that they must overcome the difficulties with the company, work hard while doing a good job of self-protection, and strive to contribute to the high-quality development of Petit! The distribution of epidemic prevention materials reflects the company's respect and care for the life and health of all employees, and truly realizes the people-oriented corporate culture. Here, I wish every employee good health and everything goes well. In this special period, let all of us Petit people play the power of the company's "create with heart and smile", unite our hearts, keep healthy, and fight the epidemic together!